Display Settings:

Format

Send to:

Choose Destination
Postgrad Med. 2005 May;117(5):9-16.

Curbing the psoriasis cascade. Therapies to minimize flares and frustration.

Author information

  • National Capital Consortium Dermatology Residency Program, National Naval Medical Center, Bethesda, Maryland, USA. dwshenenberger@bethesda.med.navy.mil

Abstract

Psoriasis, a T-cell-mediated disorder, affects 1% to 3% of the world's population. The characteristic lesions occur in many different forms, can cause significant discomfort and social distress, and in some instances, lead to dehydration and metabolic derangement. A chronic, unpredictable course and the necessity of periodically switching drugs or classes of drugs make psoriasis frustrating to treat. However, topical and systemic drug therapies and phototherapy can help minimize the exacerbations and prolong remissions. In this article, Dr Shenenberger outlines treatment approaches and discusses research into the use of immunomodulatory agents.

PMID:
15948363
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk